Vraylar 3 MG capsule 30S

Ended Awarded

Contract number
SPE2DB25FC99S
Awardee
Awarding agency
Obligated
$13,103

Award facts

Contract value 100% obligated
$13,102.65 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order valued at $13,102.65 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Vraylar 3 mg capsules (30-count units). This contract is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. Vraylar is a branded antipsychotic medication used in the treatment of schizophrenia, bipolar disorder, and major depressive disorder, representing part of the Defense Logistics Agency's broader pharmaceutical procurement needs for military and veteran healthcare systems.

This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC, designated SPE2DX, serves as a comprehensive global pharmaceutical supply vehicle enabling the company to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a major pharmaceutical distributor serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contracting vehicles that support diverse therapeutic domains and medical commodity needs.

Quick answers

Who was awarded contract SPE2DB25FC99S?

SPE2DB25FC99S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.

How much is contract SPE2DB25FC99S worth?

The government has obligated $13,103 on SPE2DB25FC99S.

Is contract SPE2DB25FC99S an order under another contract?

Yes. SPE2DB25FC99S is a delivery order under SPE2DB20D2014, an indefinite delivery contract.

Was contract SPE2DB25FC99S competed?

The extent of competition for SPE2DB25FC99S was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award